Nurix Therapeutics, Inc. · NASDAQ:NRIX

van Houte Hans sold 2,845 Nurix Therapeutics, Inc. shares (Form 4)

Traded Jul 30, 2026 · Filed Jul 30, 2026

On Jul 30, 2026, van Houte Hans (Chief Financial Officer) sold 2,845 Nurix Therapeutics, Inc. shares at US$23.38 for US$66,516, leaving 44,927 shares. Filed Jul 30, 2026 (Form 4).

Sold
2,845 shares
Price
US$23.38
Value
US$66,516
Holding after
44,927 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 30, 2026Common StockOption exercise3,75041,342Direct
Jul 30, 2026Common StockOption exercise2,85844,200Direct
Jul 30, 2026Common StockOption exercise3,57247,772Direct
Jul 30, 2026Common StockSale2,845US$23.3844,927Direct

Source

View original at SEC

Related